Prodia Diagnostic Line Tbk vs Suparma Tbk. — how do they compare? Prodia Diagnostic Line Tbk trades at Rp270 (market cap 470.58B, 28.43M 24h volume), while Suparma Tbk. trades at Rp164 (market cap 879.52B, 89.4K 24h volume). The key difference: Suparma Tbk. is the larger of the two by market cap, and Prodia Diagnostic Line Tbk is more actively traded (28.43M versus 89.4K). Which is the better fit depends on your goals.
| PRDL | SPMA | |
|---|---|---|
Market Cap | 470.58B | 879.52B |
Volume | 28.43M | 89.4K |
Lot | 284.34K | 894 |
Turnover | 7.8B | 14.68M |
Average Price | 274.19 | 164.16 |
Value | 7.8B | 14.68M |
Indicative Equilibrium Price | 270 | 164 |
Indicative Equilibrium Volume | 2.1K | 12 |
Trailing returns across standard periods
Latest headlines on both assets
PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →PT Suparma Tbk (Entity) was established under the Domestic Capital Investment Law No. 6 of 1968 as amended by Law No. 12 of 1970 based on the Notarial Deed No. 29 of Tjahjadi Hartanto, S.H., on August 25, 1976. The Entity's name, PT Supar Inpama was changed to PT Suparma based in the Notarial Deed No. 5 dated December 7, 1978 of the same notary.
Read more on SPMA →